Top 10 Holdings of Caligan Partners
Founded in 2017, Caligan Partners is one of the most significant specialty hedge funds.
Posts Tagged ‘NASDAQ:ALIM’
Alimera Sciences, Inc. (NASDAQ:ALIM) Q1 2024 Earnings Call Transcript
Operator: Ladies and gentlemen, thank you for standing by.
Alimera Sciences, Inc. (NASDAQ:ALIM) Q4 2023 Earnings Call Transcript
Operator: Ladies and gentlemen, thank you for standing by.
Alimera Sciences, Inc. (NASDAQ:ALIM) Q3 2023 Earnings Call Transcript
Operator: Ladies and gentlemen, thank you for standing by.
Alimera Sciences, Inc. (NASDAQ:ALIM) Q2 2023 Earnings Call Transcript
Operator: Ladies and gentlemen, thank you for standing by. Good morning, and welcome to the Alimera Sciences Second Quarter 2023 Financial Results Conference Call.
Alimera Sciences, Inc. (NASDAQ:ALIM) Q4 2022 Earnings Call Transcript
Operator: Ladies and gentlemen, thank you for standing by. Good morning and welcome to the Alimera Sciences 2022 Financial Results Conference Call.
Alimera Sciences, Inc. (NASDAQ:ALIM) Q3 2022 Earnings Call Transcript
Operator: Ladies and gentlemen, thank you for standing by.
10 Best Low Price Pharma Stocks To Buy Now
The global pharmaceuticals market was forecasted to grow from $1454.66 billion in 2021 to $1587.05 billion in 2022 at a compound annual growth rate (CAGR) of 9.1%.
Do Hedge Funds Love Alimera Sciences Inc (ALIM)?
At the end of February we announced the arrival of the first US recession since 2009 and we predicted that the market will decline by at least 20% in (Recession is Imminent: We...
Do Hedge Funds Love Alimera Sciences Inc (ALIM)?
In this article we will take a look at whether hedge funds think Alimera Sciences Inc (NASDAQ:ALIM) is a good investment right now.
Did Hedge Funds Drop The Ball On Alimera Sciences Inc (ALIM) ?
"The global economic environment is very favorable for investors. Economies are generally strong, but not too strong.
13G Filing: Palo Alto Investors and Alimera Sciences Inc (ALIM)
Please follow Palo Alto Investors (if you aren't already doing so) to get real-time email alerts whenever we publish an article about Palo Alto Investors or update its stock holdings...
13D Filing: Intersouth Partners VI LP and Alimera Sciences Inc (ALIM)
The remainder of this cover page shall be filled out for a reporting persons initial filing on this form with respect to the subject class of securities, and for any subsequent...
Is Alimera Sciences Inc (ALIM) A Good Stock To Buy?
At Insider Monkey we track the activity of some of the best-performing hedge funds like Appaloosa Management, Baupost, and Third Point because we determined that some of the stocks...
Alimera Sciences Inc (ALIM): Great Point Partners Reveals 5.12% Stake
Jeffrey Jay and David Kroin's Great Point Partners reported the acquisition of 3.25 million common shares of Alimera Sciences Inc (NASDAQ:ALIM) which account for 5.12% of the...
Tempur Sealy (TPX), GrubHub (GRUB), United States Steel Corporation (X) Among Top Weekly Gainers
It was a mixed week for the market last week, as the Dow gave up 0.75% of its value, while the S&P 500 was down slightly, and the Nasdaq was 1.21% in the green.
Tiger Global Cuts Stake in Autohome, While Deerfield Buys More Shares of This Pharmaceutical Company
Federal funds future contracts suggest a 79% probability that the Federal Reserve will raise interest rates at the December policy meeting, an event which is expected to halt...
Three Healthcare Stocks Hedge Funds Are Snapping Up
Is it a good time to buy Alimera Sciences Inc (NASDAQ:ALIM)? James E.
Jeffrey Ray’s Great Point Partners Trims Its Stake In Alcobra Ltd (ADHD)
Jeffrey Jay and David Kroin's healthcare-focused fund, Great Point Partners, decreased its passive stake in the Israel based biopharmaceutical company, Alcobra Ltd (NASDAQ...
Connecture Inc (CNXR), Hyperion Therapeutics Inc (HPTX): Top 5 Healthcare Picks of Great Point Partners
Jeffrey Jay and David Kroin’s Great Point Partners is one of the newer funds we track at Insider Monkey, and we’ll cover the healthcare-focused fund’s top picks for the ...
Synergy Pharmaceuticals Inc (SGYP), Proteon Therapeutics Inc (PRTO): James E. Flynn and Peter Kolchinsky Think These Stocks Look Healthy
Synergy Pharmaceuticals Inc (NASDAQ:SGYP) and Proteon Therapeutics Inc (NASDAQ:PRTO) are in the spotlight as James E.
Alimera Sciences Inc (ALIM) & Bio Blast Pharma Ltd (ORPN): 2 Pharmaceutical Stocks Hedge Funds are Increasing Their Stakes In
Pharmaceuticals and life sciences as a sector is where most of the money from hedge funds seems to be flowing in.
VIRGINIA NATL BNK (VABK), Alimera Sciences Inc (ALIM), Advanced Photonix, Inc. (API): Hedge Funds Disclose Moves In Their Equity Portfolios
Tim Mullen and his fund, Swift Run Capital Management, have sent a presentation to the management of VIRGINIA NATL BNK (OTCMKTS:VABK), in which they have outlined potential ...
